{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:36:11Z","timestamp":1747157771432,"version":"3.40.5"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalimaging.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.clinimag.2017.07.011","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T14:30:34Z","timestamp":1500561034000},"page":"34-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Outcomes of radioembolization for unresectable hepatocellular carcinoma in patients with marginal functional hepatic reserve"],"prefix":"10.1016","volume":"47","author":[{"given":"Derek M.","family":"Biederman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8718-8688","authenticated-orcid":false,"given":"Raghuram","family":"Posham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raisa J.","family":"Durrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Titano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora E.","family":"Tabori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis S.","family":"Nowakowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron M.","family":"Fischman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Lookstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8050-2366","authenticated-orcid":false,"given":"Edward","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clinimag.2017.07.011_bb0005","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"year":"2012","author":"OPTN\/SRTR","series-title":"Annual data report: liver [Internet]","key":"10.1016\/j.clinimag.2017.07.011_bb0010"},{"issue":"6","key":"10.1016\/j.clinimag.2017.07.011_bb0015","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/hep.510300629","article-title":"Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation","volume":"30","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.clinimag.2017.07.011_bb0020","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/jlts.2002.35927","article-title":"The new liver allocation system: moving toward evidence-based transplantation policy","volume":"8","author":"Freeman","year":"2002","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1016\/j.clinimag.2017.07.011_bb0025","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","article-title":"A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization","volume":"9","author":"Lewandowski","year":"2009","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"4","key":"10.1016\/j.clinimag.2017.07.011_bb0030","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2214\/AJR.15.14802","article-title":"Transarterial chemoembolization and (90)Y Radioembolization for hepatocellular carcinoma: review of current applications beyond intermediate-stage disease","volume":"205","author":"Fidelman","year":"2015","journal-title":"AJR Am J Roentgenol"},{"issue":"2 Pt 1","key":"10.1016\/j.clinimag.2017.07.011_bb0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.RVI.0000142602.79459.90","article-title":"Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis","volume":"16","author":"Goin","year":"2005","journal-title":"J Vasc Interv Radiol"},{"issue":"2 Pt 1","key":"10.1016\/j.clinimag.2017.07.011_bb0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.RVI.00001142592.89564.F9","article-title":"Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities","volume":"16","author":"Goin","year":"2005","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"10.1016\/j.clinimag.2017.07.011_bb0045","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/lt.23552","article-title":"Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction","volume":"19","author":"Garwood","year":"2013","journal-title":"Liver Transpl"},{"doi-asserted-by":"crossref","unstructured":"Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology (Baltimore, Md). 2005;42(5):1208\u201336.","key":"10.1016\/j.clinimag.2017.07.011_bb0050","DOI":"10.1002\/hep.20933"},{"issue":"3","key":"10.1016\/j.clinimag.2017.07.011_bb0055","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.clinimag.2017.07.011_bb0060","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","article-title":"Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations","volume":"17","author":"Salem","year":"2006","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"10.1016\/j.clinimag.2017.07.011_bb0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.clinimag.2017.07.011_bb0070","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00270-007-9064-z","article-title":"Radioembolization with 90Y microspheres: angiographic and technical considerations","volume":"30","author":"Lewandowski","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"10.1016\/j.clinimag.2017.07.011_bb0075","first-page":"37s","article-title":"MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates","volume":"40","author":"Siegel","year":"1999","journal-title":"J Nucl Med"},{"year":"2010","first-page":"2015","series-title":"Common Terminology Criteria for Adverse Events, Version 4.03","key":"10.1016\/j.clinimag.2017.07.011_bb0080"},{"author":"CDC","key":"10.1016\/j.clinimag.2017.07.011_bb0085"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707117301328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707117301328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T01:16:50Z","timestamp":1569892610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707117301328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":17,"alternative-id":["S0899707117301328"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2017.07.011","relation":{},"ISSN":["0899-7071"],"issn-type":[{"type":"print","value":"0899-7071"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of radioembolization for unresectable hepatocellular carcinoma in patients with marginal functional hepatic reserve","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2017.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}